| # | Drug | Count |
|---|---|---|
| 0 | AZATHIOPRINE | 46 |
| 1 | METHOTREXATE SODIUM | 46 |
| 2 | LEFLUNOMIDE | 43 |
| 3 | ACETAZOLAMIDE | 41 |
| 4 | ACETAZOLAMIDE SODIUM | 41 |
| 5 | ALENDRONATE SODIUM | 41 |
| 6 | METHOTREXATE | 39 |
| 7 | INFLIXIMAB | 35 |
| 8 | PREDNISONE | 31 |
| 9 | CYCLOPHOSPHAMIDE | 27 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACETAZOLAMIDE SODIUM | 41 | 0.0067 |
| 1 | ALCLOMETASONE DIPROPIONATE | 1 | 0.0032 |
| 2 | ERYTHROMYCIN ETHYLSUCCINATE | 1 | 0.0016 |
| 3 | ANAKINRA | 15 | 0.0009 |
| 4 | METHYLPHENIDATE HCL | 1 | 0.0008 |
| 5 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 2 | 0.0008 |
| 6 | CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | 1 | 0.0005 |
| 7 | AZATHIOPRINE | 46 | 0.0005 |
| 8 | TESTOSTERONE | 12 | 0.0005 |
| 9 | ALENDRONATE SODIUM TABLET | 8 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Purine Antimetabolite [EPC] | 46 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 44 |
| 2 | Antirheumatic Agent [EPC] | 43 |
| 3 | Carbonic Anhydrase Inhibitor [EPC] | 41 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 39 |
| 5 | Corticosteroid [EPC] | 37 |
| 6 | Alkylating Drug [EPC] | 28 |
| 7 | Calcium [EPC] | 25 |
| 8 | Calcineurin Inhibitor Immunosuppressant [EPC] | 21 |
| 9 | Topoisomerase Inhibitor [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Carbonic Anhydrase Inhibitor [EPC] | 41 | 0.0020 |
| 1 | Interleukin-1 Receptor Antagonist [EPC] | 15 | 0.0009 |
| 2 | Purine Antimetabolite [EPC] | 46 | 0.0005 |
| 3 | Androgen [EPC] | 12 | 0.0004 |
| 4 | Antirheumatic Agent [EPC] | 43 | 0.0004 |
| 5 | Antiseptic [EPC] | 1 | 0.0002 |
| 6 | Hedgehog Pathway Inhibitor [EPC] | 2 | 0.0002 |
| 7 | Topoisomerase Inhibitor [EPC] | 16 | 0.0002 |
| 8 | Recombinant Human Growth Hormone [EPC] | 4 | 0.0002 |
| 9 | Calcium [EPC] | 25 | 0.0002 |